"This (tariff) move is going to be inflationary to the U.S. as they don't have the requisite manufacturing infrastructure in-house to replace the scale of supply that India does."
Top Indian drugmakers bank on bilateral talks for relief from planned US tariffs
www.reuters.com/business/hea...
reuters.com
Top Indian drugmakers bank on bilateral talks for relief from planned US tariffs
Indian drugmakers are hoping that bilateral discussions between the country and the United States will help them steer clear of President Donald Trump's plan to levy at least 25% tariffs on pharmaceutical imports, a trade association said.